APO Research
Talk to an analyst

APO RESEARCH · REPORT

Selpercatinib Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Selpercatinib Capsules Industry Growth and Trends Forecast to 2032

27 December 202572 pages

Choose your research edition.

Industry ResearchSelpercatinib Capsules Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Selpercatinib Capsules Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Selpercatinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Selpercatinib Capsules Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Selpercatinib Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Selpercatinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Selpercatinib Capsules include Innovnent Biologics and Eli Lilly among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Selpercatinib Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Selpercatinib Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Selpercatinib Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Selpercatinib Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Selpercatinib Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Selpercatinib Capsules Market by Company

Innovnent Biologics

Eli Lilly

Selpercatinib Capsules Segment by Type

40mg

80mg

Selpercatinib Capsules Segment by Application

Thyroid Carcinoma

Non-Small Cell Lung Cancer (NSCLC)

Others

Selpercatinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Selpercatinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Selpercatinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Selpercatinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Selpercatinib Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Selpercatinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40mg Table 2. Major Company of 80mg Table 3. Global Selpercatinib Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Selpercatinib Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Selpercatinib Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Selpercatinib Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Selpercatinib Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Selpercatinib Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Selpercatinib Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Selpercatinib Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Selpercatinib Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Selpercatinib Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Selpercatinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Selpercatinib Capsules Industry Trends Table 25. Selpercatinib Capsules Industry Drivers Table 26. Selpercatinib Capsules Industry Opportunities and Challenges Table 27. Selpercatinib Capsules Industry Restraints Table 28. Global Selpercatinib Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Selpercatinib Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Selpercatinib Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Selpercatinib Capsules Sales Share by Company (2021-2026) Table 32. Global Selpercatinib Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Selpercatinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Selpercatinib Capsules Major Company Production Sites and Headquarters Table 35. Global Selpercatinib Capsules Company, Product Type & Application Table 36. Global Selpercatinib Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Selpercatinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Selpercatinib Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Selpercatinib Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Selpercatinib Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Selpercatinib Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Selpercatinib Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Selpercatinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Selpercatinib Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Selpercatinib Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Selpercatinib Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Selpercatinib Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Selpercatinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Selpercatinib Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Selpercatinib Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Selpercatinib Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Selpercatinib Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Selpercatinib Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Selpercatinib Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Selpercatinib Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Selpercatinib Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Selpercatinib Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Selpercatinib Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Selpercatinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Innovnent Biologics Company Information Table 72. Innovnent Biologics Business Overview Table 73. Innovnent Biologics Selpercatinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Innovnent Biologics Selpercatinib Capsules Product Portfolio Table 75. Innovnent Biologics Recent Development Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Selpercatinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eli Lilly Selpercatinib Capsules Product Portfolio Table 80. Eli Lilly Recent Development Table 81. North America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 83. North America Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 84. North America Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Selpercatinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 86. North America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Selpercatinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Selpercatinib Capsules Market Share by Country (2021-2026) Table 89. North America Selpercatinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Selpercatinib Capsules Market Share Forecast by Country (2027-2032) Table 91. Europe Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 93. Europe Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 94. Europe Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Selpercatinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Selpercatinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Selpercatinib Capsules Market Share by Country (2021-2026) Table 99. Europe Selpercatinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Selpercatinib Capsules Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Selpercatinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Selpercatinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Selpercatinib Capsules Market Share by Country (2021-2026) Table 109. Asia-Pacific Selpercatinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Selpercatinib Capsules Market Share Forecast by Country (2027-2032) Table 111. Latin America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 113. Latin America Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 114. Latin America Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Selpercatinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Selpercatinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Selpercatinib Capsules Market Share by Country (2021-2026) Table 119. Latin America Selpercatinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Selpercatinib Capsules Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Selpercatinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Selpercatinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Selpercatinib Capsules Market Share by Country (2021-2026) Table 129. Middle East and Africa Selpercatinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Selpercatinib Capsules Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Selpercatinib Capsules Distributors List Table 134. Selpercatinib Capsules Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Selpercatinib Capsules Image Figure 2. Global Selpercatinib Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Selpercatinib Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Selpercatinib Capsules Sales (2021-2032) & (K Units) Figure 5. 40mg Image Figure 6. Global 40mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 80mg Image Figure 8. Global 80mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Selpercatinib Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Selpercatinib Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Selpercatinib Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Selpercatinib Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Selpercatinib Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Selpercatinib Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Selpercatinib Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Selpercatinib Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Selpercatinib Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Selpercatinib Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Selpercatinib Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Selpercatinib Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Selpercatinib Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Thyroid Carcinoma Image Figure 24. Global Thyroid Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Non-Small Cell Lung Cancer (NSCLC) Image Figure 26. Global Non-Small Cell Lung Cancer (NSCLC) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Selpercatinib Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Selpercatinib Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Selpercatinib Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Selpercatinib Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Selpercatinib Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Selpercatinib Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Selpercatinib Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Selpercatinib Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Selpercatinib Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Selpercatinib Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Selpercatinib Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Selpercatinib Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Selpercatinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Selpercatinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Selpercatinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Selpercatinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Selpercatinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Selpercatinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Selpercatinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Selpercatinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Selpercatinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Selpercatinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Selpercatinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Selpercatinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Selpercatinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Selpercatinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Selpercatinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Selpercatinib Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Selpercatinib Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Thyroid Carcinoma
  • Non-Small Cell Lung Cancer (NSCLC)
  • Others
Companies covered
  • Innovnent Biologics
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Selpercatinib Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Selpercatinib Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Selpercatinib Capsules Market by Type
  6. 1.3.1 40mg
  7. 1.3.2 80mg
  8. 1.4 Global Selpercatinib Capsules Market Size by Type
  9. 1.4.1 Global Selpercatinib Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Selpercatinib Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Selpercatinib Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Selpercatinib Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Selpercatinib Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Selpercatinib Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Selpercatinib Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Selpercatinib Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Selpercatinib Capsules Industry Trends
  2. 2.2 Selpercatinib Capsules Industry Drivers
  3. 2.3 Selpercatinib Capsules Industry Opportunities and Challenges
  4. 2.4 Selpercatinib Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Selpercatinib Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Selpercatinib Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Selpercatinib Capsules Price (2021-2026)
  4. 3.4 Global Selpercatinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Selpercatinib Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Selpercatinib Capsules Company, Product Type & Application
  7. 3.7 Global Selpercatinib Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Selpercatinib Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Selpercatinib Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Selpercatinib Capsules Tier 1, Tier 2, and Tier 3
4 Selpercatinib Capsules Regional Status and Outlook
  1. 4.1 Global Selpercatinib Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Selpercatinib Capsules Historic Market Size by Region
  3. 4.2.1 Global Selpercatinib Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Selpercatinib Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Selpercatinib Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Selpercatinib Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Selpercatinib Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Selpercatinib Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Selpercatinib Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Selpercatinib Capsules by Application
  1. 5.1 Selpercatinib Capsules Market by Application
  2. 5.1.1 Thyroid Carcinoma
  3. 5.1.2 Non-Small Cell Lung Cancer (NSCLC)
  4. 5.1.3 Others
  5. 5.2 Global Selpercatinib Capsules Market Size by Application
  6. 5.2.1 Global Selpercatinib Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Selpercatinib Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Selpercatinib Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Selpercatinib Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Selpercatinib Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Selpercatinib Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Selpercatinib Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Selpercatinib Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Innovnent Biologics
  2. 6.1.1 Innovnent Biologics Company Information
  3. 6.1.2 Innovnent Biologics Business Overview
  4. 6.1.3 Innovnent Biologics Selpercatinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Innovnent Biologics Selpercatinib Capsules Product Portfolio
  6. 6.1.5 Innovnent Biologics Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Selpercatinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Selpercatinib Capsules Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
7 North America by Country
  1. 7.1 North America Selpercatinib Capsules Sales by Country
  2. 7.1.1 North America Selpercatinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Selpercatinib Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Selpercatinib Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Selpercatinib Capsules Market Size by Country
  6. 7.2.1 North America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Selpercatinib Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Selpercatinib Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Selpercatinib Capsules Sales by Country
  2. 8.1.1 Europe Selpercatinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Selpercatinib Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Selpercatinib Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Selpercatinib Capsules Market Size by Country
  6. 8.2.1 Europe Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Selpercatinib Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Selpercatinib Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Selpercatinib Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Selpercatinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Selpercatinib Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Selpercatinib Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Selpercatinib Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Selpercatinib Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Selpercatinib Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Selpercatinib Capsules Sales by Country
  2. 10.1.1 South America Selpercatinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Selpercatinib Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Selpercatinib Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Selpercatinib Capsules Market Size by Country
  6. 10.2.1 South America Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Selpercatinib Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Selpercatinib Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Selpercatinib Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Selpercatinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Selpercatinib Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Selpercatinib Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Selpercatinib Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Selpercatinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Selpercatinib Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Selpercatinib Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Selpercatinib Capsules Value Chain Analysis
  2. 12.1.1 Selpercatinib Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Selpercatinib Capsules Production Mode & Process
  7. 12.2 Selpercatinib Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Selpercatinib Capsules Distributors
  10. 12.2.3 Selpercatinib Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst